Tuesday, June 7, 2022
- 7:00pm-8:00pm
-
Engineered Adaptable Human Endothelial Cells Enable Durable Engraftment of Subcutaneously Transplanted Islets
Translational Cellular Therapies: Islet and Stem Cell Transplantation • Hynes Halls C & D
- 7:00pm-8:00pm
-
Evaluating Long Term Outcomes in Kidney Transplant Patients with TruGraf Gene Expression and TRAC Dd-cfdna in the TRULO Study
Biomarkers: Clinical Outcomes • Hynes Halls C & D
- 7:00pm-8:00pm
-
Evaluating the Performance and External Validity of Machine Learning-Based Prediction Models in Liver Transplantation: An International Study
Machine Learning, Artificial Intelligence and Social Media in Transplantation • Hynes Halls C & D
- 7:00pm-8:00pm
-
Evaluating the Risk and Benefit of Once Daily Delayed Release Mycophenolate in Pediatric Kidney Transplant Recipients
Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D
- 7:00pm-8:00pm
-
Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients
Pharmacy II • Hynes Halls C & D
- 7:00pm-8:00pm
-
Evaluation of GLP-1 Receptor Agonist Use in the Solid Organ Transplant Population
Pharmacy II • Hynes Halls C & D
- 7:00pm-8:00pm
-
Evaluation of Renal Function After Donation in Living Marginal Kidney Donor
Kidney Living Donor: Selection • Hynes Halls C & D
- 7:00pm-8:00pm
-
Expanding Access to Robotic Kidney Transplantation for Candidates with High BMI. A Training Tool for Transplant Centers
Health Equity and Access • Hynes Halls C & D
- 7:00pm-8:00pm
-
Experience with the First Two Living Donor Robotic Left Lobe Hepatectomies in the USA
Liver: Living Donor Liver Transplant and Partial Grafts • Hynes Halls C & D
- 7:00pm-8:00pm
-
Factors Associated with Ineligible Donor Use in the United States
Deceased Donor Management and Intervention Research • Hynes Halls C & D
- «Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 52
- Next Page»